Newbridge Financial Services Group, Inc. Teva Pharmaceutical Industries LTD Transaction History

Newbridge Financial Services Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$10.67 - $14.43 $74,690 - $101,010	-7,000 Reduced 88.61%	900 $12,000
Q4 2023 Mar 28, 2024	BUY	$8.12 - $10.63 $64,147 - $83,977	7,900 New	7,900 $82,000
Q4 2022 Jan 17, 2023	BUY	$7.95 - $9.48 $31,800 - $37,920	4,000 Added 67.8%	9,900 $0
Q3 2022 Oct 13, 2022	BUY	$6.86 - $11.95 $34,300 - $59,750	5,000 Added 555.56%	5,900 $48,000
Q2 2022 Jul 15, 2022	BUY	$7.38 - $10.4 $1,476 - $2,080	200 Added 28.57%	900 $7,000
Q4 2021 Jan 19, 2022	SELL	$7.9 - $10.19 $15,800 - $20,380	-2,000 Reduced 74.07%	700 $6,000
Q3 2021 Oct 27, 2021	BUY	$8.38 - $10.18 $7,542 - $9,162	900 Added 50.0%	2,700 $26,000
Q2 2021 Sep 07, 2021	BUY	$9.9 - $11.56 $10,890 - $12,716	1,100 Added 157.14%	1,800 $18,000
Q1 2021 Sep 07, 2021	SELL	$10.34 - $12.81 $2,440 - $3,023	-236 Reduced 25.21%	700 $8,000
Q3 2020 Sep 07, 2021	BUY	$8.57 - $12.69 $8,021 - $11,877	936 New	936 $8,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.